The University of Texas Medical Branch (UTMB) is celebrating a significant achievement in cancer prevention research as Abbey Berenson, MD, MMS, PhD, a professor of Obstetrics and Gynecology, has been named a recipient of the 2026 Texans Conquer Cancer Award.
Presented by the Cancer Prevention and Research Institute of Texas (CPRIT), the award recognizes grantees who exemplify scientific excellence, innovation, and meaningful impact on healthcare across Texas. Berenson is one of four recipients selected from 20 nominees statewide. Award recipients are chosen through a competitive nomination process led by fellow CPRIT-supported researchers, then reviewed by representatives of CPRIT’s advisory committees before final selection by the organization’s leadership.
Berenson was recognized for her outstanding leadership in expanding access to the human papillomavirus (HPV) vaccine in medically underserved communities and for her groundbreaking research aimed at improving cancer prevention among Texans.
“Dr. Berenson’s work demonstrates how research can directly improve lives,” said Senior Vice President of Health Affairs and Dean of the John Sealy School of Medicine Antonio Bianco, MD, PhD. “Her commitment to expanding access to preventive care and reducing barriers to HPV vaccination has helped protect thousands of Texans while advancing our understanding of effective cancer prevention strategies.”
A nationally recognized expert in women’s health, Berenson serves as director of the UTMB Center for Interdisciplinary Research in Women’s Health Care. Her research focuses on HPV vaccination, contraception, cervical cancer prevention, comparative effectiveness studies, and improving health outcomes for women throughout their reproductive years.
Since 2012, Berenson and UTMB have secured two CPRIT Academic Research grants totaling $3.5 million and 14 CPRIT Prevention grants totaling approximately $25 million. These investments have supported research and community-based initiatives designed to increase HPV vaccination rates and reduce cancer risk among vulnerable populations across Texas.
The award highlights Berenson’s contributions to the institution’s ongoing efforts to advance innovative research that improves health and prevents disease. Her work is part of a broader institutional commitment to developing evidence-based solutions that address some of Texas’ most pressing health challenges.
The Texans Conquer Cancer Award honors CPRIT grantees whose work reflects the strength of Texas’ cancer research and prevention ecosystem and demonstrates how scientific discovery can translate into measurable improvements in health outcomes for patients and communities.
For Berenson, the recognition underscores the importance of sustained investment in prevention.
“Preventing cancer before it starts is one of the most powerful tools we have to improve public health," she said. "This recognition reflects the dedication of our research teams, community partners, and the many Texans who participate in and support this work.”